Doctors Note Logo

Published on: 8/18/2026

The Science of Opioid-Induced Hyperalgesia: Why Narcotics Worsen Baseline Pain

Opioid-induced hyperalgesia (OIH) is a paradoxical state in which prolonged opioid exposure sensitizes the nervous system, making baseline pain feel worse rather than better. There are several factors to consider. See below to understand more.

Sustained opioid use triggers neuroplastic changes in the central nervous system, including activation of NMDA receptors, upregulation of excitatory neurotransmitters like glutamate and substance P, spinal glial cell activation, and descending facilitation from the rostroventral medulla. The result is a lowered pain threshold and expanding, diffuse pain that spreads beyond the original injury site, often accompanied by allodynia, meaning normally painless touch becomes painful. OIH is distinct from tolerance: with tolerance, increasing the dose restores relief, while with OIH, escalating the dose intensifies pain, and careful tapering or rotation to different agents, sometimes with NMDA antagonists like ketamine or adjuncts such as ketorolac, may paradoxically reduce it.

Because worsening pain on opioids can signal OIH, tolerance, disease progression, withdrawal, or a new condition entirely, and because these possibilities require very different responses, mapping your specific pattern of symptoms is an important first step. A free, instant, online symptom check can help you organize what you are experiencing and understand how to navigate next steps with your prescriber.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

The Science of Opioid-Induced Hyperalgesia: Why Narcotics Worsen Baseline Pain

Introduction

Opioid medications can be lifesaving for severe pain, but over time they may trigger a paradox: instead of relief, pain intensifies. This phenomenon—opioid-induced hyperalgesia (OIH)—occurs when long-term opioid use makes your nervous system more sensitive, causing higher baseline pain. Understanding OIH is crucial for anyone dealing with chronic body pain after stopping long term opioids or still taking them.

What Is Opioid-Induced Hyperalgesia?

Opioid-induced hyperalgesia is a state where ongoing opioid therapy increases your sensitivity to pain, rather than diminishing it. Key features include:

  • Widespread pain: Discomfort spreads beyond the original injury site.
  • Lower pain threshold: Everyday touches or mild discomfort become painful.
  • Heightened sensitivity: Allodynia (non-painful stimuli cause pain) and hyperalgesia (painful stimuli feel more intense).

How Opioids Trigger Hyperalgesia

Multiple biological processes drive OIH:

  1. Central Sensitization
    • Repeated opioids alter spinal neurons, making them fire more easily.
    • Overactive pain pathways amplify incoming signals.
  2. NMDA Receptor Activation
    • Opioids indirectly stimulate N-methyl-D-aspartate (NMDA) receptors in the brain and spinal cord.
    • This boosts excitatory signaling and pain perception.
  3. Neuroinflammation & Glial Cell Activation
    • Chronic opioids can activate microglia and astrocytes (brain immune cells) to release pro-inflammatory chemicals.
    • These substances sensitize nerves, intensifying pain.
  4. Impaired Descending Inhibition
    • Normally, your brain dampens pain via descending pathways.
    • Opioids may weaken these controls, tipping the balance toward more pain.

Distinguishing OIH from Tolerance and Withdrawal

It can be confusing to tell OIH apart from tolerance or withdrawal, especially when facing chronic body pain after stopping long term opioids:

  • Tolerance
    – Needing higher opioid doses for the same relief, but baseline sensitivity stays constant.
  • Withdrawal
    – After stopping opioids, aches and flu-like symptoms peak within days to weeks, then improve.
  • OIH
    – Pain worsens with dose increases or long-term use, persisting despite adjustments.

If your pain:

  • Spreads to new areas
  • Feels more intense with small dose increases
  • Persists or worsens over months of therapy
    …OIH is likely.

Recognizing Chronic Body Pain After Stopping Long Term Opioids

Many expect that pain improves once they stop opioids, but instead they may experience:

  • Heightened discomfort at original injury sites
  • New or widespread aches
  • Sensitivity to light touch or temperature changes

This rebound pain can combine OIH, withdrawal effects, and your underlying condition’s natural course. Identifying the mix helps shape the right treatment.

Strategies to Manage Opioid-Induced Hyperalgesia

Working with your doctor, these approaches can reduce hyperalgesia and improve comfort:

  1. Opioid Tapering

    • Gradual dose reduction (often 5–10% every 1–2 weeks) lessens withdrawal and hyperalgesia.
  2. Switching or Adding Medications

    • NMDA antagonists (ketamine, dextromethorphan) to counteract hyperalgesia.
    • Gabapentin or pregabalin to calm nerve sensitivity.
    • SNRIs (e.g., duloxetine) to modulate chronic pain.
  3. Non-Drug Interventions

    • Physical therapy: Graded exercise and manual therapy retrain pain pathways.
    • Cognitive-behavioral therapy (CBT): Techniques to change how you perceive pain.
    • Mind-body practices: Meditation, yoga, and relaxation exercises help rebalance your nervous system.
  4. Multimodal Pain Management

    • Combine non-opioid meds, interventional procedures (nerve blocks), and psychosocial support.
    • Regular follow-up allows dose and strategy adjustments.
  5. Lifestyle & Self-Care

    • Balanced diet, good sleep habits, and stress management support recovery.
    • Gentle, consistent movement prevents deconditioning and improves mood.

Case Example

Jane, 54, had chronic back pain and took oxycodone for five years. As her dose increased, pain spread to her shoulders and thighs. Suspecting OIH, her doctor designed a taper plan while adding an SNRI and starting physical therapy. Within months, Jane’s overall pain dropped and her energy returned.

Monitoring Progress

When to Seek Immediate Help

OIH can overlap with serious conditions. Contact your doctor or seek emergency care if you experience:

  • Sudden, severe pain unlike anything before
  • Fever, chills, or infection signs around wounds
  • New weakness, numbness, or tingling
  • Thoughts of harming yourself

Always inform any healthcare provider about your opioid use.

Conclusion

Opioid-induced hyperalgesia is a challenging but treatable condition. By recognizing the signs, working with medical professionals on tapering strategies, and integrating non-opioid therapies, you can regain better pain control. Chronic body pain after stopping long term opioids may feel overwhelming, but a personalized plan that combines medication adjustments, therapy, and lifestyle changes offers real relief.

Always speak to a doctor about anything that could be life-threatening or serious.

(References)

  • * Bannister K, Dickenson AH. Opioid hyperalgesia. Curr Opin Support Palliat Care. 2010 Mar;4(1):1-5. doi: 10.1097/SPC.0b013e328335ddfe. PMID: 20019618.

  • * Teuteberg WG. Opioid-induced hyperalgesia #142. J Palliat Med. 2010 Dec;13(12):1486-7. doi: 10.1089/jpm.2010.9752. PMID: 21155645.

  • * Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011 Mar-Apr;14(2):145-61. PMID: 21412369.

  • * Pasero C, McCaffery M. Opioid-induced hyperalgesia. J Perianesth Nurs. 2012 Feb;27(1):46-50. doi: 10.1016/j.jopan.2011.11.002. PMID: 22264622.

  • * Lee MO Jr. Opioid-induced hyperalgesia. J Clin Rheumatol. 2012 Oct;18(7):325-6. doi: 10.1097/RHU.0b013e3182733011. PMID: 23047531.

  • * Brinck EC, Tiippana E, Heesen M, Bell RF, Straube S, Moore RA, Kontinen V. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD012033. doi: 10.1002/14651858.CD012033.pub4. Epub 2018 Dec 20. PMID: 30570761; PMCID: PMC6360925.

  • * Colvin LA, Bull F, Hales TG. Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia. Lancet. 2019 Apr 13;393(10180):1558-1568. doi: 10.1016/S0140-6736(19)30430-1. PMID: 30983591.

  • * Mercadante S, Arcuri E, Santoni A. Opioid-Induced Tolerance and Hyperalgesia. CNS Drugs. 2019 Oct;33(10):943-955. doi: 10.1007/s40263-019-00660-0. PMID: 31578704.

  • * Kellett E, Berman R, Morgan H, Collins J. Parecoxib for opioid-induced hyperalgesia. BMJ Support Palliat Care. 2021 Jun;11(2):126-127. doi: 10.1136/bmjspcare-2020-002290. Epub 2020 Jun 29. PMID: 32601152.

  • * Vitin AA, Egan TD. Remifentanil-induced hyperalgesia: the current state of affairs. Curr Opin Anaesthesiol. 2024 Aug 1;37(4):371-378. doi: 10.1097/ACO.0000000000001400. Epub 2024 Jun 3. PMID: 38841986.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.